browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
eab58cc6-08bc-42fe-ad60-5cb9f386efb4
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-05-04 21:34:13
Income (reported)
$40,000
Expenses (reported)
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

SPLITOAK STRATEGIES LLC

Health care consulting

Contact
SARAH EGGE
Phone
+1 703-203-7992
Address
zip:20001, city:Washington, state:DC, street:300 New Jersey Avenue, NW Suite 300
Client

CARIS SCIENCE INC

Providing precision medicine services to patients battling aggressive cancers.

State
TX
Country
US
Government-entity client
false
Effective date
2017-09-19
Issues lobbied + lobbyists (2)

MMM — Medicare/Medicaid

Role of molecular profiling in cancer care; access to molecular profiling technologies and multi-cancer testing in Medicare; prior authorization reform in Medicare and appropriate reimbursement for cutting edge cancer diagnostic testing; HR 5269 RESULTS Act; HR 7148 the Consolidated Appropriations Act of 2026; updated timing of reporting under PAMA

Lobbyists:
  • AMY JENSEN — covered position: Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Role of Artificial Intelligence and technology in cancer diagnostics and treatment; Value of precision medicine and blood-based diagnostic tools

Lobbyists:
  • AMY JENSEN — covered position: Special Assistant to the President for Legislative Affairs; Assistant to the Speaker for Policy; Legislative Assistant; Policy Analyst

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.